[ Price : $8.95]
FDA publishes the third in a series of guidances on aspects of collecting patient experience data to be used in medical product de...[ Price : $8.95]
FDA accepts for priority review an Astellas supplemental BLA for Padcev (enfortumab vedotin-ejfv) in combination with Mercks Keytr...[ Price : $8.95]
FDA awards a fast track designation to Myosin Therapeutics and its investigational drug MT-125 for treating brain cancer.[ Price : $8.95]
FDA releases hiring data showing steep declines in staffing at CDER and CBER.[ Price : $8.95]
FDA warns St. Louis, MO-based BRS Analytical Services about CGMP violations in its production of finished drugs.[ Price : $8.95]
GSK and Spero Therapeutics report positive Phase 3 results for tebipenem HBr, an investigational oral antibiotic for complicated u...[ Price : $8.95]
FDA says it is strengthening labeling for tranexamic acid injection products to clarify that it is only to be administered intrave...[ Price : $8.95]
FDA contracts with the Institute for Safe Medication Practices for services to strengthen its ability to identify and reduce the r...